Combined with a newly developed dedicated remosaicing (array conversion) processing algorithm, the new sensor delivers 20% ...

A new computational method reveals a faster way to explore intricate quantum systems, pointing toward emerging applications in next-generation computing. Credit: Stock A new quantum-inspired algorithm ...

Lets geek out. The HackerNoon library is now ranked by reading time created. Start learning by what others read most. Lets geek out. The HackerNoon library is now ranked by reading time created. Start ...

Structure Therapeutics reported highly positive Phase 2 ACCESS II data for aleniglipron, achieving ~16% placebo-adjusted weight loss with strong statistical significance and no plateau. Aleniglipron’s ...

A Structure Therapeutics obesity pill helped patients lose an average of nearly 40 pounds in a mid-stage clinical trial, keeping the drug competitive in the growing crowd of oral medications pursuing ...

Creating a highly accurate geological model at a large scale presents a considerable challenge, primarily due to constraints imposed by sparse data availability. A promising strategy to mitigate these ...

WASHINGTON, Jan 22 (Reuters) - TikTok's Chinese owner, ByteDance, on Thursday said it has finalized a deal to establish a majority American-owned joint venture that will secure U.S. data, to avoid a U ...

Elon Musk's social network X (formerly known as Twitter) last night released some of the code and architecture of its overhauled social recommendation algorithm under a permissive, enterprise-friendly ...

Roche obtained a nonexclusive license to certain patents from Structure Therapeutics related to the Swiss pharma's oral GLP-1 candidate CT-996. (tolgart/iStock/Getty Images Plus) In a strategic move ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...